LILRB4 STAR-T Cells in the Treatment of R/R AML/CMML

NCT05548088 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Acute Myeloid Leukemia and Chronic Granulocytic-Mononocytic Leukemia

Interventions

BIOLOGICAL: LILRB4 STAR-T cells

Sponsor

Peking University People's Hospital

Collaborators

[object Object]